Comparison of efficacy and safety of salvage-line nivolumab monotherapy between 240 and 480 mg for advanced esophageal squamous cell carcinoma.

被引：0
|
作者：
Murashima, Yuko
Yamamoto, Shun
Hirose, Toshiharu
Kadono, Toru
Ikeda, Go
Ohara, Akihiro
Itoyama, Mai
Yokoyama, Kazuki
Honma, Yoshitaka
Ishiyama, Koshiro
Oguma, Junya
Daiko, Hiroyuki
Kato, Ken
机构：
[1] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
317
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma
    Qiu, Hai-Bo
    THORACIC CANCER, 2020, 11 (12) : 3419 - 3421
  • [42] Efficacy and Safety of Apatinib with or Without Radiation Therapy as Second-Line or Beyond Therapy in Patients with Advanced/Recurrent Esophageal Squamous Cell Carcinoma
    Li, T.
    Lv, J.
    Wang, Q.
    Fan, Y.
    Wang, J.
    Song, Y.
    Liang, L.
    Wu, L.
    Lang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E33 - E34
  • [43] The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma
    Chen, Ming-Qiu
    Chen, Cheng
    Lu, Hai-Jie
    Xu, Ben-Hua
    JOURNAL OF THORACIC DISEASE, 2015, 7 (10) : 1749 - 1755
  • [44] Efficacy and safety of pembrolizumab combined with albumin-bound paclitaxel and nedaplatin for advanced esophageal squamous cell carcinoma
    Yan, Fang
    Chen, Longpei
    Ying, Mingzhen
    Li, Jie
    Fu, Qiang
    IMMUNOTHERAPY, 2024, 16 (05) : 305 - 317
  • [45] A Prospective Clinical Study On The Efficacy And Safety Of Anlotinib In The Treatment Of Recurrent / Metastatic Advanced Esophageal Squamous Cell Carcinoma
    Li, K.
    Li, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E609 - E609
  • [46] The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma
    Shen, Dijian
    Chen, Qixun
    Wu, Jie
    Li, Jianqiang
    Tao, Kaiyi
    Jiang, Youhua
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (01) : 1 - 10
  • [47] Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma.
    Sheng, Liming
    Du, Xianghui
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma
    Zhao, Zheng
    Yin, Ming-Mei
    Zhao, Wei-Feng
    Wang, Chao-Jie
    MEDICINE, 2023, 102 (33) : E34794
  • [49] The Efficacy and safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin, 5-FU therapy for resectable locally advanced esophageal squamous cell carcinoma
    Ogura, N.
    Yamamoto, S.
    Hirose, T.
    Shiraishi, K.
    Imazeki, H.
    Itoyama, M.
    Yokoyama, K.
    Honma, Y.
    Kurita, D.
    Ishiyama, K.
    Oguma, J.
    Daiko, H.
    Seto, Y.
    Kato, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S1479 - S1479
  • [50] Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma
    Liu, Shixian
    Dou, Lei
    Wang, Kaixuan
    Shi, Zhao
    Wang, Ruixue
    Zhu, Xiaohong
    Song, Zehua
    Li, Shunping
    FRONTIERS IN ONCOLOGY, 2022, 12
12345